Bone Biologics (BBLG) Return on Sales (2016 - 2017)
Historic Return on Sales for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to 1.9%.
- Bone Biologics' Return on Sales fell 231700.0% to 1.9% in Q4 2017 from the same period last year, while for Dec 2017 it was 1.59%, marking a year-over-year decrease of 234800.0%. This contributed to the annual value of 2.0% for FY2021, which is 1700.0% up from last year.
- Per Bone Biologics' latest filing, its Return on Sales stood at 1.9% for Q4 2017, which was down 231700.0% from 1.91% recorded in Q3 2017.
- In the past 5 years, Bone Biologics' Return on Sales registered a high of 39.55% during Q1 2016, and its lowest value of 1.06% during Q2 2017.